ICD-10-PCS › X New Technology › XW Anatomical Regions › XW2 New Technology, Anatomical... › XW24346

XW24346

Transfusion of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6

RetiredICD-10-PCS procedure code.

No longer in the code set. Submitting it will not be accepted for a current date of service.

Billable FY2021 only. In the code set FY2021 only, and removed after that.

Use instead:

  • XW043M7 Introduction of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 stated for FY2021

What has happened to this code

Every change the publisher made, from 2021 to now.

  1. FY2021 Added to the code set Transfusion of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6
  2. FY2022 Removed from the code set

Codes in the same group

CodeDescriptionStatus
XW23346 Transfusion of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6 Retired
XW23376 Transfusion of Lisocabtagene Maraleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6 Retired
XW24376 Transfusion of Lisocabtagene Maraleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6 Retired